Study Title: A Phase III, Randomized, Open Label, Multicenter Study of Lurbinectedin in Combination with Atezolizumab Compared with Atezolizumab as Maintenance Therapy in Participants with Extensive Stage Small Cell Lung Cancer (ES SCLC) Following First Line Induction Therapy with Carboplatin, Etoposide and Atezolizumab
For more information about the trial above please contact the study team: